Skip to content
Search

Latest Stories

Women can visit community pharmacies for advice and treatment for uncomplicated UTIs

Women can visit community pharmacies for advice and treatment for uncomplicated UTIs

Over 3,500 women in Northern Ireland made use of the Pharmacy UTI service between March 2022 and April 2023   

Thanks to the Pharmacy First service, women in the UK can now be assessed and treated for uncomplicated Urinary Tract Infections (UTIs) much sooner by local pharmacists without having to wait for a GP appointment.


In Northern Ireland, more than 400 community pharmacies are now providing the UTI management service, which is available for women aged 16 to 64, according to the Department of Health NI.

In a statement released on Tuesday (5 December), the department ensured the public that all community pharmacists providing this service are qualified healthcare professionals with the training and ability to test and treat UTIs.

The participating community pharmacies will offer a confidential consultation in a private area where patients can discuss their symptoms with the pharmacist, who may test the patient’s urine to help determine if a UTI is present.

Self-care advice may be only needed in some UTI cases, but the community pharmacist can also supply the patient with medicines to relieve pain and if appropriate, an antibiotic, when necessary.

All women with urinary tract infections (UTI) visiting participating community pharmacies will be advised what to do if their symptoms worsen or do not resolve, the department added.

“Urinary Tract Infections can be extremely uncomfortable and it’s thought that up to 50 per cent of women will experience one during their lifetime,” said Joe Brogan, Assistant Director, Pharmacy and Medicines Management, Department of Health.

Not only the Pharmacy First UTI service does away with the need for a GP appointment, but women can be assessed and treated much sooner as “community pharmacies are more likely to be open after normal working hours, at weekends and bank holidays,” he added.

Be aware of UTI symptoms

Women are advised to watch out for symptoms of a UTI that include: burning or stinging sensation on passing urine, needing to pass urine frequently or urgently, cloudy urine, and passing excessive or large quantities of urine.

The acceptance of the UTI management service has increased significantly in Northern Ireland, following the positive evaluation of a pilot that involved around 60 pharmacies since July 2021.

Stephen Toland, Pharmacist at Murphy’s Pharmacy, Derry who has been providing this service since 2021 said: “The feedback from patients has been overwhelmingly positive. They’re really happy that they are able to get same day advice and treatment from a health professional all close to home, for a condition that can be very distressing.”

Over 3,500 women in the country benefited the pilot service between March 2022 and April 2023.  Following assessment, more than 85 per cent of these women were diagnosed with a UTI and received appropriate advice and treatment from the pharmacist.

During this period, more than 5 per cent of patients were referred to their GP or Out of Hours service.

Patients do not need to take an appointment for the Pharmacy First UTI service, they can simply request a consultation with a pharmacist of the community pharmacists providing this service.

However, Pharmacy First for everyday health conditions is available at all community pharmacies in Northern Ireland, the health department informed.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less